Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Fondazione Neoplasie Sangue Onlus Identifier:
First received: March 24, 2010
Last updated: February 5, 2016
Last verified: February 2016